Global Cetrotide Market Size, Share and Trends Analysis Report, By Type (Vial with Powder and Pre-filled Syringe), By Distribution Channel (Hospital Pharmacies and Retail Pharmacies), Forecast (2022-2028)

The global cetrotide market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Cetrotide is also known as Cetrorelix that belongs to the class of medications called GnRH antagonists. The major factor expected to drive the market is that it blocks the effects of gonadotropin-releasing hormone GnRH. In addition, GnRH controls the secretion of another hormone, called luteinizing hormone (LH), a hormone that starts ovulation (release of an egg) during the menstrual cycle. Furthermore, Cetrotide also allows the release of an egg to be controlled so it is released at the best time for pregnancy to occur, these are the factors that drive market growth. Furthermore, the market is growing as Cetrotide medication starts suppression hormone production in the pituitary gland almost as soon as it is administered in compression to any other fertility medication.

Cetrotide is also known as Cetrorelix is a subcutaneous injection that is prescribed to women undergoing controlled stimulation treatment. The medication supports to prevent a rise in luteinizing hormone (LH) levels, which can trigger early ovulation. It regulates the functioning of the pituitary gland. Further this gland is responsible for the production of hormones that stimulate the growth of an egg, its development, and release once it is mature.

Some major players in the market include Merck kGaA, and Ferring Pharmaceuticals BV, among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in September 2021, Ferring International Center S.A. collaborate with Hybio Pharmaceutical Co. Ltd. where the Marketing Authorization of Cetrotide (cetrorelix acetate for injection) in Mainland China will be transferred to Ferring Pharmaceuticals; and Hybio Pharmaceutical will act as the contract manufacturing organization of Ferring Pharmaceuticals.

Market Coverage

• The market number available for – 2022-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Type
  • By Distribution Channel
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

 

• Competitive Landscape– Merck kGaA, and Ferring Pharmaceuticals BV, among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Cetrotide Market Report by Segment

By Type

• Vial with Powder
• Pre-filled Syringe

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies

Global Cetrotide Market Report by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa